In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


DTC Advertising Under Pressure

Executive Summary

Direct to consumer advertising is a double-edged sword for pharma manufacturers: It boosts sales of their products, but it also leaves them vulnerable to negative public perception. In the eight years since the FDA first permitted DTC for durgs, the noted benefits have largely outweighed the potential for damage. But several factors are combining to shift the equation and now even proponents are clamoring for change. IN VIVO interviews industry experts to get their opinion of the current status and future direction of DTC.

Related Content


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts